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ABSTRACT
Isothermal amplification assays, such as loop-
mediated isothermal amplification (LAMP), show
great utility for the development of rapid diagnos-
tics for infectious diseases because they have high
sensitivity, pathogen-specificity and potential for im-
plementation at the point of care. However, elimina-
tion of non-specific amplification remains a key chal-
lenge for the optimization of LAMP assays. Here, us-
ing chlamydia DNA as a clinically relevant target and
high-throughput sequencing as an analytical tool, we
investigate a potential mechanism of non-specific
amplification. We then develop a real-time digital
LAMP (dLAMP) with high-resolution melting temper-
ature (HRM) analysis and use this single-molecule
approach to analyze approximately 1.2 million ampli-
fication events. We show that single-molecule HRM
provides insight into specific and non-specific ampli-
fication in LAMP that are difficult to deduce from bulk
measurements. We use real-time dLAMP with HRM to
evaluate differences between polymerase enzymes,
the impact of assay parameters (e.g. time, rate or flo-
rescence intensity), and the effect background hu-
man DNA. By differentiating true and false positives,
HRM enables determination of the optimal assay and
analysis parameters that leads to the lowest limit of
detection (LOD) in a digital isothermal amplification
assay.
INTRODUCTION
Isothermal methods, such as loop-mediated isothermal am-
plification (LAMP), are attractive for nucleic acid amplifi-
cation tests (NAATs) in point-of-care and limited-resource
settings (1,2). LAMP in particular shows promise as a
NAAT with fewer hardware requirements compared with
polymerase chain reaction (PCR) (3). Despite advance-
ments, the ability to optimize LAMP NAATs for a specific
target sequence and primer set (specific to a target organ-
ism) remains constrained by a limited understanding of how
amplification is affected by myriad factors, including poly-
merase choice, primer design, temperature, time and ion
concentrations. In particular, addressing non-specific am-
plification remains a core problem as it constrains an as-
say’s limit of detection (LOD). In reactions containing tem-
plate target molecules, both specific and non-specific am-
plification reactions may occur. Unlike PCR, LAMP lacks
a temperature-gating mechanism, so non-specific reactions
consume reagents and compete with specific amplification
impacting its kinetics. The presence of non-specific ampli-
cons therefore adversely impacts both the assay’s analytical
sensitivity (the fewest template molecules that can be de-
tected) and its analytical specificity (ability to detect the tar-
get template in the presence of competing reactions). Clas-
sifying reactions as either specific or non-specific amplifica-
tion would therefore be invaluable both during assay opti-
mization and assay deployment in clinical diagnostics.
Substantial research is focused on using isothermal am-
plification chemistries for diagnosis of infectious disease.
For example, chlamydia (caused by the pathogen Chlamy-
dia trachomatis, CT) is the most common sexually transmit-
ted infection worldwide, with more than 110 million cases
reported annually (4). Diagnosis of CT infections is chal-
lenged by a lack of standard symptoms (many infections
are asymptomatic) (5) and the presence of mixed flora (par-
ticularly in the female reproductive tract) (6). Thus, rapid
NAATs with high sensitivity and specificity are critically
needed, especially NAATs that can deal with the high levels
of host or background DNA likely to be present in clinical
samples such as urine samples and swabs (7,8).
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Optimizing LAMP for CT and other infectious
pathogens requires addressing and reducing non-specific
amplification or a method for separating non-specific
reactions from specific amplification. Reactions run in
bulk (i.e. in a tube) in the absence of template can be
informative to provide information on performance of
non-specific amplification. Another method to identify
non-specific amplification includes mathematical modeling
in conjunction with electrophoresis to distinguish between
non-specific and specific banding patterns (9). However, in
the presence of template, although specific and non-specific
reactions occur simultaneously, they cannot be monitored
simultaneously. Thus, bulk reactions have three important
limitations with regard to assay optimization: (i) differ-
ences in the kinetics of specific and non-specific reactions
cannot be separated, (ii) rare but significant events, such as
early but infrequent non-specific amplification, cannot be
easily characterized; and (iii) testing the full design space
requires many hundreds of replicates to obtain statistically
significant data. To improve an assay’s analytical specificity
and sensitivity, one strategy is to eliminate the detection
of non-specific amplification. In bulk LAMP experiments,
non-specific amplification can be excluded from detection
by using probes, beacons, FRET or reporter-quencher
schemes that show only specific amplification of the target
(10–19). Although these methods improve the assay, they
do not capture non-specific reactions and thus cannot give
insights into the origin of non-specific amplification or
the conditions that led to non-specific amplicons. More-
over, probes and beacons do not eliminate non-specific
amplification; non-specific amplification still competes
for reagents and can limit the extent of the signal gen-
erated by specific amplification events (20). Hence, it is
highly desirable to distinguish specific from non-specific
amplification.
In this study, we combined sequencing and digital single-
molecule LAMP (dLAMP) with high-resolution melting
temperature (HRM) to probe the fundamental mechan-
ics of amplification reactions. We used dLAMP to ex-
tract real-time kinetic information to identify the digital
threshold data-processing parameters that minimize non-
specific amplification events and elucidate how an interfer-
ing molecule impacts amplification. Digital single-molecule
methods separating individual amplification events into dis-
crete compartments, eliminating interference among indi-
vidual amplification events (21,22). Furthermore, digital
experiments consist of thousands of reactions that run in
parallel and thus provide valuable statistical information
(21–23). We used real-time imaging to monitor the kinet-
ics of 20,000 dLAMP reactions per experiment and observe
∼1.2 × 106 reactions in total. We hypothesized that high-
resolution melting analysis (HRM) could be a tool for sep-
arating specific from non-specific amplification events and
for identifying the optimal digital threshold data-processing
parameters to distinguish specific and non-specific ampli-
fication events (even when an assay is deployed without
HRM). To test this hypothesis, we used a dLAMP assay
with CT DNA as the target (combined with sequencing to
identify the products of bulk reactions) to analyze both spe-
cific and non-specific amplification under conditions that
include clinically relevant concentrations of background
human DNA.
MATERIALS AND METHODS
LAMP reagents
IsoAmp I (#B0537S), IsoAmp II (#B0374S), MgSO4
(#B1003S), deoxynucleotide solution (#N0447S), Bovine
Serum Albumen (BSA, #B9000S0), Bst 2.0 (8,000 U/ml,
#M0537S) and Bst 3.0 (8000 U/ml, #M0374S) were pur-
chased from New England Biolabs (Ipswich, MA, USA).
Ambion RNase Cocktail (#AM2286), Ambion nuclease-
free water (#AM9932), Invitrogen SYTO 9 (S34854) and
Invitrogen ROX Reference Dye (#12223012) were pur-
chased from Thermo Fisher Scientific (Waltham, MA,
USA). We found it important to use SYTO 9 dilutions
within one week of preparation.
Primers sequences were targeted against the Chlamy-
dia trachomatis 23S ribosomal gene using Primer Explorer
V5 (Eiken Chemical, Tokyo, Japan) and checked in Snap-
Gene (GSL Biotech, Chicago, IL, USA) to ensure the se-
quences were in a mutation free region from the available
Genebank sequences of CT. Primers were purchased from
Integrated DNA Technologies (San Diego, CA, USA) and
suspended in nuclease-free water. For all experiments, the
final concentrations of primers were 1.6 M FIP/BIP, 0.2
M FOP/BOP and 0.4 M LoopF/LoopB. Primer se-
quences are listed in Supplementary Materials and Meth-
ods.
LAMP experiments using Bst 2.0 were amplified at 68◦C
in nuclease-free water, with final concentrations of: 1×
IsoAmp I Buffer, 7mM total MgSO4 (5 mM additional),
1.4 mM each dNTP, 1.25 uM ROX Reference Dye, 1 mg/ml
BSA, 320 U/ml Bst 2.0, 1× Ambion RNase Cocktail and 2
M SYTO 9.
LAMP experiments using Bst 3.0 were amplified at 69◦C
in nuclease-free water, with final concentrations of: 1×
IsoAmp II Buffer, 8 mM total MgSO4 (6 mM additional),
1.4 mM each dNTP, 1.25 M ROX Reference Dye, 1 mg/ml
BSA, 320 U/ml Bst 3.0, 1× Ambion RNase Cocktail and 2
M SYTO 9.
For both enzymes, after 90 min of amplification, reac-
tions were ramped to 95◦C at maximum output and held
for 30 s to inactivate the enzymes. Chips were cooling to
55◦C and the melt performed at a ramp rate of 1◦C per im-
age from 55–90◦C, and a ramp rate of 0.5◦C per image from
90–95◦C.
Extraction of spiked Chlamydia trachomatis (CT) from a rel-
evant clinical matrix
A frozen stock of live CT (D-UW3, Z054, Zeptometrix,
Buffalo, NY, USA) was re-suspended in pre-warmed (37◦C)
SPG buffer (219 mM sucrose, 3.7 mM KH2PO4, 8.5 mM
NA2HPO4, and 4.9 mM L-glutamate) buffer to 1 × 108
IFU/ml. It was then diluted 10-fold into a freshly donated
urine sample to 1 × 107 IFU/ml. Urine from a healthy
human donor (>18 years of age) was acquired and used
in accordance with approved Caltech Institutional Review
Board (IRB) protocol 15-0566. Written informed consent
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was obtained from all participants, donations were never
tied to personal identifiers and all research was performed
in accordance with relevant institutional biosafety regula-
tions. A 250 l aliquot from this CT-spiked urine sam-
ple was then extracted following the ZR Viral DNA/RNA
Kit protocol (#D7020, Zymo Research, Irvine, CA, USA).
Briefly, 250 l of CT-spiked urine was mixed with 250 l
DNA/RNA shield and 1000 l DNA/RNA Viral Buffer.
A total of 1500 l (750 l × 2) was added to the column
and centrifuged at 16 000 × g for 1 min. Then, 500 l Viral
Wash buffer was added to the column and centrifuged at 16
000 × g for 2 min. Then, 60 l DNAse/RNAse-free water
was added directly to the column and centrifuged at 16 000
× g for 30 s. The eluent was treated by adding 2.5 l Am-
bion RNAse Cocktail (#AM2286, ThermoFisher) to 47.5
l template. Stocks were prepared in 0.5 × TE buffer and
dilutions quantified using the QX200 droplet digital PCR
system (Bio-Rad Laboratories, Hercules, CA, USA), outer
primers at 500 nM each and 1× EvaGreen Supermix (Bio-
Rad).
Fabrication of thermoelectric unit and mount
A Thermoelectric Module (VT-127-1.4-1.5-72), Thermis-
ter (MP-3022), Controller (TC-720) and 12V Power Supply
(PS-12-8.4; TE Tech, Traverse City, MI, USA) were wired
according to the manufacturer’s instructions.
While the Peltier can be used out of the box, we manu-
factured a heat plate and sink to improve the efficiency in
the cooling mode. Instructions for fabrication can be found
in the Supplementary Materials and Methods, ‘Fabrication
of thermoelectric unit mount.’ The ability of the embedded
thermocouple to accurately assess temperature of the alu-
minum block was verified with an independent K-type mini-
thermcouple read through a General IRT659K [IR] Ther-
mometer.
Shearing of genomic DNA
Human genomic DNA from buffy coat leukocytes (Roche
(via Sigma Aldrich), #11691112001) was fragmented us-
ing a Covaris Focused Ultrasonicator M220 (Woburn, MA,
USA) equipped with 130 L microTUBE AFA Fiber Snap-
Cap at 50W peak power, 5% duty factor, 200 cycles per
burst, for 80 s. Fragment concentration was determined us-
ing a Qbit 3 Fluorimiter (ThermoFisher, #Q33216) with
dsDNA HS assay kit (ThermoFisher, #Q32851) and mean
fragment size determined as 365 bp using an Agilent 4200
TapeStation (#G2991AA, Agilent, Santa Clara, CA, USA)
and High Sensitivity D5000 ScreenTape (#5067-5592) with
ladder (#5190-7747), and D100 ScreenTape (#5067-5584)
with High Sensitivity D1000 Reagents (#5067-5585). Dilu-
tions were prepared with a final concentration of 0.5× TE
buffer.
Microfluidic chips
Microfluidic chips for dLAMP (#A26316; Applied Biosys-
tems, Foster City, CA, USA) were loaded as we have de-
scribed previously (23) at a concentration where ∼40%
of partitions would fluoresce (corresponding to the Pois-
son maximum single template per partition loading of 660
cp/l). We estimated the volume of each partition to be 750
pl. To achieve this concentration of template molecules, we
diluted template stocks from storage in 0.5× TE to ∼0.03×
TE for all experiments. Genomic DNA (gDNA) stocks, also
stored in 0.5× TE, were diluted to a final concentration of
0.077×. Thus, the total final concentration of TE for all ex-
periments of was ∼0.1081× TE buffer.
Microscopy data collection
Data were collected in 30-s intervals using a DMI-6000B
microscope (Leica, Buffalo Grove, IL, USA) equipped with
a 1.25 × 0.04NA HCX PL FLUOTAR Objective and 0.55×
coupler (Leica C-mount 11541544). The response from
SYTO 9 was recorded using a 1.5-s exposure through an
L5 (GFP) Nomarski prism, while the ROX Reference Dye
was collected using a 1-s exposure through a Texas Red
prism. Images were collected using a Hamamatsu ORCA-
ER CCD camera (Hamamatsu Photonics K.K., Hama-
matsu City, Japan) at 100 gain. Temperature was recoded
using the built-in features of the TC-720 Controller in ∼1 s
intervals and correlated to the images via image metadata.
In these experiments, we chose to use a microscope, in-
stead of the custom real-time amplification instrument we
used previously (23,24), because the microscope has su-
perior optical properties (greater pixels per partition and
lower exposure time requirements) to access higher tempo-
ral resolution and enhanced kinetic measurements.
MATLAB script processing
The MATLAB script processes a .txt file with temperature-
time data generated from the TE Tech Controller and a TIF
stack containing 2-channel images of the LAMP and melt
curve from the LEICA microscope. Partitions are identified
using a custom iterative thresholding algorithm and labels
are propagated throughout the TIF stack using a custom la-
beling algorithm. Average well intensity is tracked over time
to generate LAMP curves and plotted against temperature
to generate the melt curves. Complete details of the script
are in the Supplementary Materials and Methods, ‘MAT-
LAB script.’
Bulk LAMP reactions were conducted in 10 l volumes
within a well plate on a CFX96 Real-time Thermocycler
(Bio-Rad) at buffer conditions and temperatures matching
the dLAMP reactions.
Enzymatic digestions of bulk LAMP products were con-
ducted using CAC8I (#R0579S), Hpy166II (#R0616S),
ACCI (#R0161S), AciI (#SR0551S), MseI (#R0525S) and
HpyCH4III (#R0618S) purchased from New England Bio-
labs and were conducted in 50 l reaction volumes contain-
ing 1 l enzyme, 1 g DNA, in 1 × Cut Smart Buffer and
incubated for 1 h at 37◦C. Samples were inactivated for 1 h
at 80◦C and diluted to 1 ng/l (∼1:300) to run on an Agilent
4200 TapeStation using High Sensitivity D5000 ScreenTape
(#5067-5592) with ladder (#5190-7747), and D100 Screen-
Tape (#5067-5584) with High Sensitivity D1000 Reagents
(#5067-5585).
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Library preparation and sequencing
The 300–500 ng of amplified DNA products were frag-
mented to the average size of 200 bp with Qsonica Q800R
sonicator (power: 20%; pulse: 15 s on/15 s off; sonication
time: 12 min) and libraries were constructed using NEB-
Next Ultra™ II DNA Library Prep Kit (NEB, #E7645)
following manufacturer’s instructions. Briefly, fragmented
DNA was end-repaired, dA tailed and ligated to NEBNext
hairpin adaptors (NEB, #E7335). After ligation, adapters
were converted to the ‘Y’ shape by treating with USER en-
zyme and DNA fragments were size selected using Agen-
court AMPure XP beads (Beckman Coulter, #A63880) to
generate fragment sizes between 250 and 350 bp. Adaptor-
ligated DNA was PCR amplified with five cycles followed
by AMPure XP bead clean up. Libraries were quanti-
fied with Qubit dsDNA HS Kit (ThermoFisher Scientific,
#Q32854) and the size distribution was confirmed with
High Sensitivity DNA Kit for Bioanalyzer (Agilent Tech-
nologies, #5067). Libraries were sequenced on Illumina
HiSeq2500 in single-read mode with the read length of 50
nt to the sequencing depth of 10 million reads per sample,
following manufacturer’s instructions. Base calls were per-
formed with RTA 1.18.64 followed by conversion to FASTQ
with bcl2fastq 1.8.4.
Sequencing analysis
Raw FASTQ files were first analyzed with FastQC v0.11.8.
Overrepresented sequences were compared with input
primer sequences to find reads consisting of potential prod-
ucts from the LAMP reactions. To verify that all adjoining
products were accounted for the FASTQ files were aligned
to the predicted products using Bowtie2 v2.3.4.3 with global
very-sensitive settings. Unaligned reads were checked for
any remaining possible amplification products. All regions
consisting of sequences from multiple primers were tallied
by counting the reads with a substring of n = 11 from the
end of each primer. One adjoining region between primers
contained a random insertion of nucleotides and was ana-
lyzed by first extracting all reads containing the primer be-
fore and after the random nucleotides. The length and se-
quence distribution of random inserts was then analyzed
from the extracted reads.
RESULTS AND DISCUSSION
Bulk LAMP studies reveal non-specific products with high
melting temperature (Tm)
We first wished to test whether melting temperature (Tm)
could be used to separate specific and non-specific ampli-
fication in a LAMP assay run in bulk. To start, we se-
lected a concentration near the LOD where we might ob-
serve both specific and non-specific amplification. We used
extracted CT genomic DNA in the presence of two com-
mercially available polymerases, Bst 2.0 and Bst 3.0, with
CT 23S as the amplification target. At target molecule con-
centrations of 10 copies per L (cp/l), amplification using
Bst 2.0 polymerase began between 10–11 min (Figure 1A)
and had uniform Tm (Figure 1B). Amplification using Bst
3.0 polymerase (Figure 1C), also yielded amplification from
10–11 min; however, we also observed a non-specific am-
plification at 15 min, defined as having a different Tm than
the specific amplification events (Figure 1D). This indicated
Bst 3.0 could be a useful model for studying non-specific
amplification. We observed that early amplifying products
corresponded to specific amplification events, and the later
products corresponded to non-specific amplification, sup-
porting our prediction that we could use Tm as a proxy for
sequence identity, as is common with PCR and has been
used previously in LAMP (25–29).
Using Bst 3.0 at low concentrations of target is a useful
system to study non-specific amplification. To investigate
the role of the concentration of the target on the incidence of
non-specific amplification, we performed half-log dilutions
of template from 10 to 0.316 cp/l. At 3.16 cp/l (Figure
1E and F), only specific amplification occurred (24 repli-
cate wells/plate). However, once template concentrations
reached 1 cp/l (Figure 1G and H), non-specific amplifi-
cation occurred with greater frequency than specific ampli-
fication (18 of the 24 replicates generated false positives).
Similarly, for 0.316 cp/l (Figure 1I and J) 15 of the 24 repli-
cates generated false positives. We next ran the same assay in
the absence of template (no-template control, NTC) (Figure
1K and L). Even though we did not expect amplification, we
observed all reactions amplified. A total of 44 of 45 repli-
cates amplified at a Tm of 91◦C, consistent with the Tm of
non-specific amplification in the presence of template. Al-
though it is possible for a reaction to generate multiple dif-
ferent non-specific amplification products, even ones with
Tm matching to the specific products, the single amplicon
observed at 88◦C in the NTC was a contaminant that ap-
peared to have the same sequence as the specific products
(Figure 2A [well F8]). In general, when the specific target
was present, it amplified sooner and outcompeted the non-
specific amplification, thereby reducing the number of ob-
servations of non-specific amplification. To determine if the
non-specific amplification was inherent to the polymerase
or a consequence of buffer selection, we conducted addi-
tional studies using both Bst polymerases (Supplementary
Figure S1 and Table S1).
To better understand non-specific amplification in
LAMP, we investigated the sequence identity of the non-
specific products with high Tm using sequencing and gel
analysis and compared them with the specific products. The
Tm of specific amplification differed between the two poly-
merases tested. Specific amplification for Bst 2.0 had a Tm
of 85.5◦C, whereas specific amplification using Bst 3.0 had
a Tm of 88◦C, and demonstrated non-specific amplification
at Tm of 91◦C. The non-specific amplification had identi-
cal Tm to amplification in absence of template (Figure 1K
and L). Despite the specific amplification products of Bst
2.0 and Bst 3.0 producing similar gel banding patterns (Fig-
ure 3) and the same sequencing results (see Figure 2B), they
had different Tm (Figure 1B and D, respectively). We deter-
mined the difference in Tm was due to differences in buffer
conditions (Supplementary Figure S1 and Table S1).
In all bulk reactions, we observed non-specific products
with high Tm. This was surprising because in PCR primer
dimers have low Tm; moreover, in previous demonstrations
of LAMP, Tm was lower for non-specific compared with
specific products (27). Thus, we investigated the sequence
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Figure 1. Amplification and Tm curves of Chlamydia trachomatis in a bulk reaction show non-specific amplification products with high Tm. Plots of
fluorescence as a function of time during a LAMP reaction (A, C, E, G, I and K) and the derivative plot of fluorescence as a function of temperature for the
corresponding melting curves (B, D, F, H, I and J). Reactions using Bst 2.0 at 10 copies per microliter (cp/l) (A and B), and using Bst 3.0 at 10 cp/l (C
and D), 3.16 cp/l (E and F), 1 cp/l (G and H), 0.316 cp/l (I and J), and without template (K and L). Reactions of specific amplification are different
shades of blue; non-specific amplification is different shades of red. The number of false-positive reactions is reported within each panel as N/Nreaction
False. NTotal for all conditions = 159 reactions.
identity of the non-specific product with high Tm. We ran
the LAMP products on a gel and observed that the char-
acteristic pattern of the specific amplification products dif-
fered substantially from the banding pattern seen in the
high-Tm non-specific products (Figure 3). Interestingly, the
high-Tm non-specific product had a ladder pattern resem-
bling that of specific LAMP products.
To determine the identity of the high-Tm non-specific
products, we performed next generation sequencing (NGS).
We observed that the non-specific products lacked the cor-
responding target sequence and identified the product as a
mixture of full-length FIP, BIP and their complements, as
well as fragments of BIP (Figure 2A).
To confirm the sequence identity of the amplicon, we
targeted the FIP and BIP regions using several restriction
endonucleases. Digestion of the specific and non-specific
products resulted in different banding patterns than the
undigested samples, and was consistent with the presence
of both FIP and BIP endonuclease recognition sites within
the sequence (Supplementary Figure S2). Specific amplifi-
cation products were 47% GC; non-specific amplification
products were 53% GC.
A proposed mechanism for formation of non-specific product
We hypothesize a mechanism for the formation of the non-
specific product with high Tm originating as a consequence
of interactions of the Bst polymerase and LAMP inner
primers. Other potential mechanisms include LIMA (30)
and UIMA (31), but are inconsistent with our sequencing
results, which observe nearly equal reads of the forward
and reverse strand as measured by counting the comple-
mentary sequences between each junction. Our proposed
mechanism requires properties that have been observed
with Bst enzymes: a strand-displacing polymerase lacking
3′-5′ exonuclease activity––common to polymerases from
thermophilic bacteria (32,33), template switching ability to
allow synthesis across a discontinuous template (33), ter-
minal transferase activity, or the ability to perform non-
templated synthesis (32,34–35). Briefly, the non-specific
product likely arises from extension of a low probability
homo-dimerization of the Backward Inner Primer (BIP),
followed by elongation across a discontinuous junction
(‘template switching’) to form a double-stranded prod-
uct incorporating Forward Inner Primer (FIP). Through
breathing of the molecule, the 3′ of one strand may form
a second hairpin and amplify. Some of these amplification
events incorporate several random nucleotides via termi-
nal nucleotidyl transferase activity resulting in a pool of
hairpins with 3′ randomers. Sequences with complemen-
tary randomers are selected in vitro to amplify. The double-
stranded product of this amplification can, through in-
tramolecular hydrogen bonding, form two dumbbell-like
structures and amplify in a fashion similar to the standard
LAMP mechanism, but primed by BIP. Repetitive cycles of
self-priming and hairpin priming by BIP result in numerous
sequences with complementarity and the possibility of mul-
tiple replication loci within a single molecule. This process
can give rise to very long amplicons, and even a branched,
mesh-like network from the multimeric sequences anneal-
ing to their neighbors or in a self-complementary fash-
ion. A simplified version of this mechanism, annotated
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Figure 2. Quantification of junctions using next-generation sequencing of select Chlamydia trachomatis amplification products from bulk reactions. Non-
specific amplification from the no-template control using Bst 3.0 (A), including amplification of a specific target contamination (well F8) corresponding
to Figure 1K and L. Amplification in the presence of 10 cp/l template (B), using Bst 2.0 (wells A1-A3) corresponding to Figure 1A and B, and Bst 3.0
(wells C1-C3) corresponding to Figure 1C and D. Non-specific amplification in the presence of 10 cp/l template and Bst 3.0 (well C7) corresponding to
Figure 1C and D. For a complete list of abbreviations used in this figure, see Supplementary Table S2.
Figure 3. Composite image of select Chlamydia trachomatis amplification
products from a bulk reaction. Products were collected using D5000 tape
on an Agilent TapeStation. Amplification in the presence of 10 cp/l tem-
plate using Bst 2.0 (lanes A1-A3) corresponding to Figure 1A and B, and
Bst 3.0 (lanes C1-C3, C7) corresponding to Figure 1C and D. Non-specific
amplification in the no-template control (NTC; lanes E2-H1) correspond
to Figure 1K and L. Contrast was determined using the automatic ‘scale
to sample’ feature in the Agilent TapeStation analysis software.
with sequencing data, can be found in Supplementary
Figure S3.
In more detail, a potential mechanism of formation
of non-specific products is as follows: initially, a double-
stranded amplicon is generated by homo-dimerization of
BIP, and 3′ extension of the homodimer to produce a par-
tial reverse complement of BIP (prcBIP) (Figure 4-1). Bst
polymerase is highly prone to mismatched extension (36),
and the two base pairs of CG provide a sufficient anchor-
ing in the 3′ to start elongation. Multiple Primer Analyzer
(ThermoFisher) does not identify the BIP homodimer, un-
less maximum sensitivity is used. Alternatively, BIP-prcBIP
product may arise from a single stranded BIP-hairpin, as
has been observed by others (37), although UNAfold (IDT)
does not predict the formation of the hairpin for this primer.
These structures may not need to be abundant at equilib-
rium, but as long as they are extended by the polymerase,
the product will be stabilized and will accumulate.
Upon accumulation of the BIP-prcBIP construct, the re-
verse complement of FIP (rcFIP) is incorporated by tem-
plate switching (Figure 4-2). The 3′ of FIP is within spa-
tial proximity of the homo-BIP sequence due to microho-
mology of to 5′ end of the double-stranded sequence cou-
pled with rapid breathing of two base pairs of TA. This al-
lows temporary insertion and hybridization of FIP with the
double-stranded BIP-prcBIP sequence (Figure 4-3). When
the polymerase is also in proximity of this reaction, FIP
slips out of the junction, and the polymerase elongates
across the 3′ discontinuous junction (33,35) templated by
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Figure 4. Illustration of a mechanism for formation of non-specific amplification products in LAMP reactions. Putative structures and intermediates are
labeled with numbers. Forward sequences are illustrated as a straight line, and the reverse compliment as a wavy line of matching color. Abbreviations used
in this figure: BIP, Backward Inner Primer; rcBIP, Reverse compliment of BIP; FIP, Forward Inner Primer; rc FIP, Reverse Compliment of FIP; prcFIP,
Partial Reverse Compliment of FIP.
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FIP (Figure 4-4). We confirmed the interaction of FIP and
BIP produced the high-Tm non-specific amplification, and
that elimination of 3′ microhomology could significantly
reduce high-Tm non-specific amplification (Supplementary
Figures S4–6 and Tables S3–4). After elongation, the FIP
which has served as template, is poised to prime in the op-
posite direction (Figure 4-5). This either displaces the ini-
tial BIP mispairing (BIP*) or opens the hairpin, resulting
in a double-stranded BIP-prcBIP-FIP product (Figure 4-6).
This three part junction is observed as a complete product
in NGS data. Breathing of double-stranded BIP-prcBIP-
FIP is prone to formation of an intramolecular self-priming
hairpin of rcBIP-pBIP (Figure 4-7). Elongation of the 3′
hairpin results in a double-stranded FIP-pBIP-rcBIP-rcFIP
hairpin (Figure 4-8) and displacement of a BIP-prcBIP-
rcFIP hairpin (Figure 4-9), which may be primed by FIP
to restart this cycle (Figure 4-10). With each amplification,
and re-prime by FIP, a single product is generated. This pro-
cess of hairpin accumulation would cause the linear ‘rins-
ing’ baseline observed by other researchers (37).
Within this pool of linear amplifying products, the Bst
enzyme will randomly incorporate additional nucleotides
at the 3′ end of FIP-pBIP-rcBIP-rcFIP via terminal trans-
ferase activity (Figure 4-11). Our sequencing methods are
unable to observe a FIP-randomer hairpin because adapter
ligation requires double-stranded products. This pool of
hairpins with random sequences will accumulate until
LAMP selects for sequences that amplify by sharing com-
plementary 3′ ‘toe holds’ (Figure 4-12). Much like in vitro
evolution, those sequences with the highest probability of
amplification are selected (32). The lack of a thermal gating
mechanism in LAMP and lack of 3′–5′ exonuclease activity
makes the amplification reaction especially prone to in vitro
evolution of self-amplifying products. When considered in
this light, it is unsurprising that non-specific amplification
could arise from mechanisms similar to the specific prod-
ucts. Within a given bulk reaction, variation in randomer se-
quence length and identity was low. However, between dif-
ferent samples, randomer sequences of multiple lengths and
identities were observed. These two results further suggest
that in bulk reactions amplification occurs from one or a
few sequences (Supplementary Table Groups S5–7).
Elongation from the randomer overhang results in a
double-stranded products, leading to dumbbell structures,
and LAMP-like amplification. First, elongation of hairpins
with complementary randomer toe holds produces a dimer
of FIP-BIP-prcBIP-rcFIP coupled through the randomer
(Figure 4-13). Breathing of the molecule can result in for-
mation of intramolecular hairpins, and eventual disassoci-
ation into two separate self-priming, dumbbell shaped hair-
pins (Figure 4-15 and -16). The products of elongation from
self-priming amplification doubles the amount of dsDNA
present and forms sequences with internal hairpins capa-
ble of priming by BIP (Figure 4-17). Elongation from BIP
priming creates a new double-stranded product and reveals
a self-priming 3′ hairpin of the original strand (Figure 4-
18), which upon elongation, displaces the sequence primed
by BIP (Figure 4-19) while transforming the trimer of FIP-
BIP-prcBIP-rcFIP to a pentamer (more than tripling the
amount of ds products from structures 15 and 16). The pen-
tamer still contains an rcBIP hairpin, and may amplify in
a functionally similar method as previously (Figure 4-17).
The displaced product Figure 4-19 is similar to Figure 4-
16 but missing 5′-FIP. However, similar to Figure 4-16, this
product is self-priming and produces a structure with an
internal rcBIP hairpin (Figure 4-20). A second priming of
the hairpin by BIP of the rcBIP-pBIP hairpin and subse-
quent elongation, creates a new double-stranded product
and reveals a self-priming 3′ hairpin of the original strand
(Figure 4-21). As previously, upon elongation, the sequence
primed by BIP is displaced (Figure 4-22). Simultaneously,
the self-priming event turns the FIP-BIP-prcBIP trimer to a
pentamer, which may continue to be amplified by BIP. The
released sequence (Figure 4-22) is again self-priming, and
whose product is equivalent to Figure 4-20 to restart the
cycle. Further, amplified hairpins may, in addition to BIP
priming of the hairpin, duplicate through self-priming by
breathing and formation of a 3′ rcBIP-pBIP hairpin (Fig-
ure 4-23).
The products of these reactions are capable of forming a
branched, mesh-like network resulting in the observed high
temperature melting. Products may experience random in-
ternal priming by through hairpin formation (e.g. Figure 4-
13,-17,-20), or 3′ self-priming (Figure 4-23). Consequently,
multiple replication loci may exist within a single strand
and products may have internal stem loop structures (Fig-
ure 4-24). Furthermore, in addition to intramolecular bond-
ing, the highly repetitive nature of these products allows for
melting of internal fragments, which reanneal to self in a
different conformation, or a neighboring strand.
Though the initial steps of generating a double-stranded
hairpin will be unique to our particular primer set, once
a seed is generated, the processes of template switching
and terminal transferase activity should be a general phe-
nomenon associated with non-specific amplification of ther-
mophilic polymerase resulting in exponential amplification.
As evidence, when the mechanism of seed formation is dis-
rupted through elimination of the microhomology, ampli-
cons with high Tm still occur, albeit with lower frequency
and delayed occurrence (Supplementary Figures S4–6 and
Tables S3–4). Template switching and non-template synthe-
sis are 100× slower than template extension (33). However,
once the self-amplifying products are selected, the reaction
follows standard exponential LAMP enrichment. Thus, ac-
cumulation of a sufficient pool of randomers may take time,
but still result in a delayed bulk exponential amplification
event. Furthermore, should a hairpin with attached ran-
domer form, it is possible that the rising baseline, attributed
to hairpin formation (37), may also by in vitro selection of
the products, lead to and result in spontaneous exponential
amplification.
Melting temperature differentiates specific and non-specific
reactions in dLAMP
To study specific and non-specific amplification events
at the digital single-molecule level, we developed a new
approach that enabled HRM analysis (obtaining ‘melt
curves’) to be performed on each partition. We used a com-
mercially available microfluidic chip with 20,000 partitions
and a previously published open-source dLAMP method
accessible to most standard laboratories (23) with the fol-
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/48/7/e42/5760753 by C
alifornia Institute of Technology user on 10 April 2020
PAGE 9 OF 21 Nucleic Acids Research, 2020, Vol. 48, No. 7 e42
lowing improvements: incorporation of an off-the-shelf
thermoelectric unit to both heat and cool the chips, and an
enhanced MATLAB script to allow for multicolor tracking.
We used the temperature-independent fluorophore ROX to
track each partition’s location and the dsDNA intercalating
fluorophore SYTO 9 to follow amplification and hybridiza-
tion status. This two-channel approach is required to follow
a partition through both amplification and the entirety of
the HRM when fluorescence from SYTO 9 is lost.
As an illustration of the capabilities of our approach, we
first used real-time dLAMP to study the kinetic parame-
ters of individual reactions and we used Tm to classify reac-
tion outcome (Figure 5). Using real-time dLAMP, we fol-
lowed individual partitions as they amplified as a function
of time (Figure 5A) and then by temperature as they went
through HRM (Figure 5B). Real-time imaging of individual
partitions enables us to reconstruct the standard amplifica-
tion curves of intensity for each partition as a function of
time (Figure 5C), and plotting the fluorescence intensity as
a function of temperature yields an HRM trace (Figure 5D);
the negative derivative plot (Figure 5E) of this melt trace is
the standard melt curve. Analogous to bulk measurements,
the standard melt curve is used to classify reactions as spe-
cific or non-specific. We used these classifications to identify
important patterns in the kinetics of each type of amplifica-
tion (Figure 5F–H).
We next used real-time dLAMP with HRM to determine
whether differences in time to positive (TTP) were due to
a difference in amplification initiation or in rate. We expect
this information would be valuable for elucidating whether
the molecules that lead to bulk amplification are the ones
that are first to initiate or the ones that initiate with the
fastest rates. We found that TTP can be heterogeneous while
Tm is constant (28.6 ± 8.9 min with 87.5 ± 0.2◦C), indi-
cating that the same product may initiate at different times
(Figure 5F). This is consistent with our knowledge of the
stochastic initiation of LAMP (23,38–39). Further, we ob-
served some variability in the maximum rate despite similar
Tm (23.7 ± 6.8 RFU/30 s, with 87.5 ± 0.2◦C Tm), which
indicates the same product may amplify at different veloci-
ties (Figure 5G). In general, we observed that maximum rate
often corresponded to the point when the reaction first be-
gan to amplify. By plotting rate as a function of TTP (Figure
5H) we observed little fluctuation in rate across a range of
different TTPs (23.7 ± 6.8 RFU/30 s with 28.6 ± 8.9 min),
indicating that the differences in TTP are mostly delays in
the initiation of amplification rather than differences in the
rate of amplification.
The use of real-time data revealed heterogeneity in the
timing of amplification initiation and the amplification rate,
but homogeneity in Tm, indicating stochasticity in initiation
of amplification. In some cases, outlier data points for rate
occurred. To determine whether removing these outliers im-
pacted the distribution of enzymatic rates, we performed a
non-parametric test (Supplementary Figure S7) and found
no significant differences in enzymatic rates when these out-
liers were excluded.
We next asked whether we could observe in dLAMP
the same pattern of high-Tm non-specific amplification and
low-Tm specific amplification that we observed in bulk.
We performed dLAMP using three chips containing tem-
Figure 5. Specific amplification in digital single-molecule experiments us-
ing Bst 2.0. (A) Fluorescence micrographs of individual partitions are
traced over time. For simplicity, we illustrate a subset of 250 of 20,000 pos-
sible partitions at three time points (0, 20 and 45 min). Of the 250 parti-
tions in this micrograph, 30 partitions amplified. Partitions A and B are
visible at 20 min; partition C becomes visible at 45 min. (B) Fluorescence
micrographs of individual partitions are traced across temperatures dur-
ing an HRM experiment. As the double-stranded DNA in each partition
de-hybridizes, the intercalating dye is released and fluorescence decreases.
(C) Plotting the fluorescence intensity as a function of time generates the
standard amplification traces of individual partitions generated during a
90-min LAMP experiment. Orange curves correspond to partitions A–C
from panel A. (D) Traces of fluorescence intensity as a function of tem-
perature for individual partitions during melting experiments. By quanti-
fying real-time intensity of individual partitions as temperature increases,
melting traces are obtained. Temperature resolution is 1◦C from 55–90◦C,
and 0.5◦C from 90–95◦C. (E) The derivative plot of panel D generates the
standard melting curve. The temperature at which the derivative maximum
occurs corresponds to the ‘melting point’ of the LAMP products in the in-
dividual partition. (F) The time each partition reached a fluorescence in-
tensity of 250 RFU (TTP) as a function of temperature. (G) Maximum rate
as a function of Tm for each partition. (H) TTP as a function of maximum
rate for each partition.
plate, and three chips lacking template (NTC) and observed
∼55,000 partitions for each condition. Although 60 000
partitions are possible, not all partitions filled nor can all
partitions be tracked for the full duration of an experiment.
For the melt curve, fluorescence readings were taken at 1◦C
increments from 55–90◦C; and at 0.5◦C increments from
90–95◦C to give higher resolution. Due to slight differences
in the timing between the heating element and the image col-
lection, some chips were observed at slightly different tem-
peratures (<0.5◦C).
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Our approach enabled us to differentiate specific and
non-specific amplification events using HRM. When us-
ing the polymerase Bst 2.0 and template (Figure 6A, blue
points), we observed a large band of amplification in the
temperature range 88.5–90.3◦C, in agreement with the Tm
observed when performing the reaction in bulk (Figure 1).
In contrast, the NTC (Figure 6A, red points) had very few
amplification events in that temperature range (68 out of 51
279 partitions). Hence, we defined events that occurred in
the Tm range 88.5–90.3◦C as true positives (specific ampli-
fication events) and we defined those that occurred outside
this range (in both the NTC and in the presence of tem-
plate) as false positives (non-specific amplification events).
When using the polymerase Bst 3.0, we observed a large
band of amplification from 91.25 to 92.75◦C in the presence
of template (Figure 6B, blue points) that did not correspond
with amplification in the NTC (Figure 6B, red points) so we
defined these as specific amplification events. As with bulk
measurements, we determined the difference in Tm between
specific amplification events between Bst 2.0 and Bst 3.0 was
due to the difference in buffer composition (Supplementary
Figure S1 and Table S1).
During these experiments, we observed two common pat-
terns. First, the Tm for specific amplification events was 3–
5◦C lower in digital compared with bulk measurements. We
attribute this difference to temperature calibration; the ther-
mocycler is calibrated to the liquid temperature, whereas
the thermoelectric element measures the temperature of the
heating element. Second, false positives in the NTC had pre-
dominantly high Tm, which we attribute to the non-specific
product we identified in the bulk reactions. We also ob-
served differences in total amplification events between the
two polymerases. Assays with Bst 3.0 resulted in substan-
tially more non-specific amplification than those with Bst
2.0 and confirmed this was not an issue with buffer selec-
tion (Supplementary Figure S1 and Table S1). After 90 min,
Bst 3.0 yielded 15 200 non-specific events (out of 54 337 ob-
served paritions) in the NTC, whereas Bst 2.0 yielded only
74 non-specific events (out of 51 279) in the NTC. Occasion-
ally, outliers occurred in the NTC and would be misidenti-
fied as positives by fluorescence and Tm. For Bst 3.0 this
occurred in 29 partitions; for Bst 2.0, it occurred in only 3
out of ∼55,000 partitions.
Next, we tested whether TTP is different for specific
and non-specific amplification. Because LAMP follows a
‘winner-takes-all’ format, frequent and early non-specific
amplification events may dominate bulk amplification. In
general, for both Bst 2.0 and Bst 3.0, specific amplifica-
tion had earlier TTP than non-specific amplification, al-
though there was some overlap, mostly >90.5◦C (Figure 6A
and B). We were able to distinguish the clustering of high-
Tm non-specific products separately from specific amplifica-
tion using a threshold of 88.5–90.3◦C (Figure 6C and Sup-
plementary Figure S8A). We illustrate each partition with
only partial opacity so that when false positives in the NTC
(red) overlap with false positives in the template-containing
sample (blue), the overlap of multiple colors appears pur-
ple (Figure 6D). Color intensity indicates the abundance of
paritions at a given TTP and temperature. To further illus-
trate how this approach can be used to differentiate spe-
cific and non-specific amplification, we next selected a re-
gion where both specific and non-specific products were ob-
served. For Bst 3.0, we were able to distinguish the clus-
tering of high-Tm non-specific products separately from
specific amplification using the threshold of 91.25–92.75◦C
(Figure 6E) and we observed better separation of specific
and non-specific amplification than with Bst 2.0 (Figure 6F
and Supplementary Figure S8B). Both enzymes had highly
variable TTP, which we have observed previously (23) and
attribute to stochastic initiation of LAMP. Bst 2.0 had both
earlier specific amplification and later non-specific amplifi-
cation than Bst 3.0. Bst 2.0 reactions containing template
generally started at 10 min, whereas non-specific amplifica-
tion began at ∼40 min. In contrast, Bst 3.0 reactions con-
taining template began at 11.5 min and non-specific ampli-
fication began at ∼20 min.
Next we asked whether there is a difference between the
maximum rates of specific and non-specific amplification.
Previously, we demonstrated that rate could be used to cor-
rect for some non-specific amplification using Escherichia
coli 23S primers (23), so we wished to test whether we could
use maximum rate as a way to differentiate specific and non-
specific amplification. Generally, specific and non-specific
amplification reactions did not have the same maximum
rate. For Bst 2.0, non-specific amplification tended to have a
slower max rate than specific amplification, although there
was some overlap (Figure 6G). At high Tm, the cluster-
ing of non-specific amplification in both the presence of
template and in the NTC were observed at >90.5◦C and
below ∼50 RFU/30 s (Figure 6H). For Bst 3.0, although
there was substantial overlap, we again observed that non-
specific amplification tended to have slower maximum rate
than specific amplification (Figure 6I). Examining the high-
Tm amplification events, non-specific amplification collects
above 92.75◦C and has maximum rate extending out to 75
RFU/30 s (Figure 6J). For both enzymes, overlap between
specific and non-specific amplification was similar and spe-
cific amplification tended to be faster. However, the max-
imum rate of specific amplification between the two en-
zymes differed; Bst 2.0 had a maxium rate of 150 RFU/30
s, whereas Bst 3.0 did not exceed 100 RFU/30 s. Bst 2.0 per-
forming faster than Bst 3.0 is consistent with our previous
observations using an E. Coli 23S primer set (23). Addition-
ally, the maximum rate of non-specific amplification in Bst
2.0 tended to be lower than non-specific amplification in Bst
3.0 (50 and 75 RFU/30 s, respectively). Consequently, the
extent of overlap of specific and non-specific amplificaiton
was greater for Bst 3.0 than Bst 2.0.
We observed an unexpected relationship between the fi-
nal intensity of each partition and the maximum rate of that
partition. After 90 min of amplification, a partition should
theoretically reach a fluorescence maximum whereby all
reagents are consumed, amplification plateaus and thus the
final intensity would be independent of the maximum rate
of amplification. However, surprisingly, we observed a gen-
eral scaling between the maximum rate and the final in-
tensity of the partition. For Bst 2.0, all amplification in
the NTC has final intensity <1017 RFU and maximum
rate <53.4 RFU/30 s. In the presence of template, 79.7%
of non-specific amplification and 52.3% of specific ampli-
fication had final intensity and maximum rate less than
these thresholds. For Bst 3.0, 87.7% of amplification in the
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Figure 6. Properties of specific and non-specific amplification using real-time kinetics and Tm. Blue indicates amplification events in the presence of
template, red indicates amplification in the absence of template (NTC). Among these amplification events, true positives were identified using Tm (88.5–
90.3◦C for Bst 2.0 and 91.25–92.75◦C using Bst 3.0). Color intensity indicates the abundance of paritions at a given TTP and temperature (partitions in
panels A, C, D, G, H, K, M using Bst 2.0 are rendered at 20% opacity in the NTC and in the presence of template; panels B, E, F, I, J, L, N using Bst 3.0
are rendered at 5% opacity in the NTC and 20% in the presence of template. (A) Tm of individual amplification events as a function of TTP using Bst 2.0.
(B) Tm of individual amplification events as a function of TTP using Bst 3.0. (C) Individual partitions with Tm between 88 and 95◦C as a function of TTP
using Bst 2.0. (D) Individual partitions with Tm between 88 and 95◦C and TTP between 60 and 70 min using Bst 2.0. Dashed line at 90.3◦C indicates the
upper threshold separating specific and non-specific amplification. (E) Individual partitions with Tm between 91 and 95◦C as a function of TTP using Bst
3.0. (F) Individual partitions with Tm between 91 and 95◦C and TTP between 35 and 45 min using Bst 3.0. Dashed line at 92.75◦C indicates the upper
threshold separating specific and non-specific amplification. (G) Tm of individual amplification events as a function of maximum rate using Bst 2.0. (H)
Tm of individual amplification events between 88 and 95◦C as a function of maximum rate using Bst 2.0. (I) Tm of individual amplification events as a
function of maximum rate using Bst 3.0. (J) Tm of individual amplification events between 88 and 95◦C as a function of maximum rate using Bst 3.0. (K)
The final intensity of individual amplification events as a function of maximum rate using Bst 2.0. (L) The final intensity of individual amplification events
as a function of maximum rate using Bst 3.0. (K and L) Partitions with a final intensity <250 RFU (dotted line) were excluded from analyses. (M) The
maximum rate of individual amplification events as a function of TTP using Bst 2.0 and (N) using Bst 3.0. (O) Plot of maximum rate from false-positive
amplifications in NTC (red), false positives amplifications in the presence of template (blue) and true-positive amplifications by Tm (black) as a function
of TTP using Bst 2.0 and (P) using Bst 3.0. (Q) 3D plots comparing maximum rate, Tm, TTP and final intensity of individual partitions using Bst 2.0 and
(R) using Bst 3.0.
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NTC has final intensity <1017 RFU and maximum rate
<53.4 RFU/30 s. In the presence of template, 89.0% of non-
specific amplification but only 45.6% of specific amplifica-
tion fell within these thresholds using Bst 3.0. Thus, false
positives were generally dimmer and had slower maximum
rates than most true-positive events. When examining the
brightest partitions, Bst 2.0 (Figure 6K) and Bst 3.0 (Fig-
ure 6L) exhibit a similar maximal final intensity near 3000
RFU. These maxima are also surprising, considering our
12-bit camera is capable of imaging up to 4096 RFU (the de-
tector was not at saturation). We suspect that this maxima
corresponds to consumption of one of the reagents; while
scaling between maximum rate and final intensity occurs
when stochastically initiated reactions have not completely
amplified, resulting in partitions dimmer than the maxima
and proportional to their rate of amplification.
During these dLAMP experiments, we also observed a
relationship between maximum rate and TTP. In bulk reac-
tions, the first and fastest amplification event determines the
reaction outcome by consuming all of the reagents. Thus,
we hypothesized that reaction conditions that promote fast
and early amplification in the NTC would lead to a high
false-positive rate in bulk and thus misidentification of am-
plification. In both Bst 2.0 (Figure 6M) and Bst 3.0 (Figure
6N) we observed a general trend of fast amplification events
occurring earlier, and slow events occurring later. In Bst 2.0,
we observed greater heterogeneity in TTP and rate than in
Bst 3.0. Furthermore, non-specific amplicons in the NTC
tended to produce slower and later amplification events. Oc-
casional outliers occurred at both fast and early times.
Next, to explicitly test whether fast and early events cor-
respond to specific amplification, we analyzed the relation-
ship between a partition’s TTP, its maximum rate, and Tm.
In the first 12 min of amplification, we observed six non-
specific amplification events in Bst 2.0 (four in the presence
of template; two in the NTC; Figure 6O), and we observed
13 non-specific events in Bst 3.0 (10 in the presence of tem-
plate; three in the NTC; Figure 6P). For both polymerases,
we were able to distinguish the rare, fast and early non-
specific amplicons from true positives. For Bst 2.0, these
non-specific amplifications were slower than the fastest true
positives, and occurred at similar times. In contrast, for Bst
3.0, the earliest amplification events were false positives and
tended to have similar rates to the true positives. We hypoth-
esize that in bulk reactions, the fast and early non-specific
amplification events (as seen in Bst 3.0 Figure 6P) lead to
non-specific measurements, whereas non-specific amplifica-
tion that coincides with specific amplification, but proceeds
at a slower rate (as seen in Bst 2.0 Figure 6O), would still
produce specific amplification in bulk. This hypothesis is
corroborated by sequencing of bulk LAMP reactions (Fig-
ure 2). Though individual bulk reactions may be assigned
a homogeneous label as ‘true positive’ or ‘false positive’ by
Tm, sequencing identifies multiple products within each re-
action and the Tm is determined by the dominant product.
For example, we observed a ‘false positive’ by Tm (Figure
1C and D), despite the presence of template. The sequencing
of this product, contained non-specific product sequences,
similar to those observed in the NTC, at high prevalence,
as well as the specific target sequences in low abundance
(Figure 2 [well C7]). Similarly, though ‘true positive’ is as-
signed to other bulk reactions in the presence of template,
the non-specific products are still observed at low abun-
dance (e.g. Figure 2 [well F8]). Further, a greater number of
non-specific partitions in digital using Bst 3.0 than Bst 2.0,
is correlated with a greater number of non-specific reads de-
spite the presence of template in the sequencing data (Com-
paring Figures 6A-B and 2B group A versus C). We hypoth-
esize that the combination of real-time parameters (such as
rate and TTP), combined with the ability of digital assays
to yield probabilities and to assign reaction identity through
HRM, may ultimately help researchers optimize bulk reac-
tion conditions.
A complex interplay exists among TTP, max rate, final inten-
sity and Tm
To better visualize how TTP, max rate, final intensity and
Tm data are interrelated, we next plotted these data in a
four-dimensional (4D) space (Figure 6Q-R, Supplemen-
tary Videos S1 and 2). We observed that among all parti-
tions, regarless of if the product was specific or non-specific
amplificiation, fluorescence was brighter when amplifica-
tion occurred earlier and faster. This was true for both
polymerases. Additionally, we observed two types of non-
specific amplification. The first type of non-specific was the
traditional ‘primer-dimer’ cloud, which is characterized by
a low Tm, low final fluorescence intensity, a slow max rate
and a generally late TTP. The second type of non-specific
cloud matches only in its high Tm, and spans a wide range
of rates, TTP and final intensities. The high-Tm non-specific
amplification occurs with greater frequency than the low-
Tm non-specific amplification. The major differences be-
tween the polymerases can also be resolved with this visual-
ization. The number of non-specific amplification events is
much fewer for Bst 2.0 than for Bst 3.0. Further, these non-
specific events in Bst 2.0 never achieve same fluorescene in-
tensity or maximum rate as with Bst 3.0. We include the 4D
representation as part of our MATLAB code, and as videos
in the Supplementary Data.
Classification of true or false positives enables optimal anal-
ysis parameter selection
We next asked whether using a combination of digital real-
time parameters, in conjunction with Tm, could be used to
improve the performance (LOD) of a dLAMP assay. For
any given assay, there is a large combination of possible pa-
rameters (e.g. amplification rate, TTP, fluorescence inten-
sity) that are used to determine when a digital partition is
‘on’ or ‘off.’ Use of these parameters and selection of thresh-
olds will influence assay performance (analytical specificity
and sensitivity). Assay performance is affected by amplifi-
cation time and the combination of choices of parameters
used to process the data impacting LOD, the probability of
detecting a molecule (efficiency), and the clinical sensitiv-
ity and specificity. Having established that there is a direct
relationship between Tm, sequence identity and structure,
we determined that Tm allows us to explicitly differentiate
specific and non-specific amplification in dLAMP, and thus,
differentiate true from false positives.
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We foresee two separate situations of dLAMP analysis
using HRM. First, where HRM is not incorporated in the fi-
nal assay, but is used during assay development. Second, the
ideal situation for quantitative performance, where HRM
is incorporated into the final LAMP assay. We expect the
first group of LAMP assays to exist because collecting Tm
data adds additional time to an assay and requires more
advanced hardware to run. This may be unideal in situa-
tions requiring more rapid diagnostics or limited-resource
and field settings where the hardware may be impractical.
Nonetheless, running HRM is still useful during LAMP as-
say development to select the optimal combination of pa-
rameters for end-point or real-time LAMP without using
Tm. Hence, Tm allows one to identify the correct combina-
tion of assay parameters, and how to analyze the data for
best LOD.
LOD is a key parameter when optimizing clinical assays
because pathogen load is low in many infections (e.g. in
blood infections or asymptomatic sexually transmitted in-
fections). We thus illustrated the optimization of parame-
ters using improved LOD as the selection criteria. The com-
bination of real-time dLAMP with HRM can uniquely de-
fine LOD because of the combination of digital and Tm.
Unlike bulk assays, which require a concentration titration
curve (and are thus dependent on integrated signal inten-
sity and enzymatic turnover), digital assays only require that
an event (target molecule) is or is not observed and can be
counted relative to the partition volume (40,41). The mini-
mum LOD for any digital assay corresponds to one target
or amplification event per partition volume. Hence, we can
define LOD from a single concentration point by Equation
(1):
LOD = CTrue
[NTrue −
(
NFalse + 3 ×
√
NFalse
)
]/NCI
(1)
where CTrue is the concentration of target molecules loaded
by ddPCR counts in copies per microliter, NTrue is the num-
ber of true positive (specific) amplification events observed
on a chip, NFalse is the number of non-specific amplification
events observed on a chip and NCI is the number of expected
molecules for a given confidence interval. In this equation,
the NTrue and NFalse are chip-specific, and take into account
the total volume of the chip, the number of partitions and
the volume of partitions. Furthermore, in Equation (1), am-
plification efficiency is implicitly taken into account via the
NTrue parameter (in other words, for a less efficient amplifi-
cation process, a given CTrue on a given chip would lead to
a lower value of NTrue). For simplicity, Equation (1) makes
the assumption that the measurements are performed at suf-
ficiently low concentrations (as is typical for LOD experi-
ments) that only a very small fraction of occupied partitions
contain more than one molecule and therefore there is a lin-
ear relationship between CTrue and NTrue.
The concentration loaded, CTrue, generates N total counts
of both true- and false-positive events. We can divide this
concentration by the minimal number of counts needed to
identify a specific amplification event and define this as the
LOD. The minimum number of counts needed to guaran-
tee a specific amplification event is observed is determined
by NTrue, NFalse and NCI. NTrue and NFalse are determined
empirically, whereas NCI is calculated from the desired ex-
pected number of molecules that will yield at least one de-
tection event for a given confidence interval (NCI) from
the Poisson equation. If we require a 95% CI to observe
a true positive across an entire chip, the minimum num-
ber of counted events is 3 (i.e. 5% of the time, the Poisson
expected loading of three target molecules will still mea-
sure zero events.) For a 98% CI, NCI would be four counts.
Hence, all true-positive counts in excess of NCI are counts
observed above the LOD. Uncertainty in the LOD is given
by Supplementary Equations S1–2.
Counting only true positives does not account for inter-
ference from false positives. In order to meet our minimum
counts for detection, our equation must remove false counts
(NFalse). The generally accepted procedure for LOD calcula-
tions with a 99.7% CI is to assign NTrue only when the counts
exceed the background plus three standard deviations of the
background (NFalse + 3 ×
√
NFalse). We approximate the
variance in the background using the counting error as three
times the square root of the number of false-positive events
counted and subtract those counts from the true-positive
counts to yield the equation.
Using this calculation of LOD to optimize an assay has
three limitations. First, Equation (1) fails to produce a num-
ber with physical meaning when the number of true-positive
events (NTrue) is less than the number of false-positive events
plus three times the standard deviation in false amplifica-
tion (NFalse + 3 ×
√
NFalse). In this case, it is not possible
to conclusively observe a true positive, and the LOD be-
comes irrelevant. Second, Equation (1) gives an absolute
LOD. The numerator (concentration of template molecules
loaded on the chip, as determined by PCR) is corrected
for the probability of observing a molecule amplify (effi-
ciency) by the true-positive counts. NFalse accounts for the
non-specific amplification, and NCI accounts for the Pois-
son probability associated with loading a target molecule.
Third, this equation is specific to digital assays.
We first sought to demonstrate the selection of optimal
parameters for situations where HRM is not incorporated
into the final assay. Using this process, one can pick any
threshold and use Tm to determine the optimal trade-off
between true and false positives. All initial experiments test-
ing the utility of LOD, juxtaposed against receiver operat-
ing characteristic (ROC) curves, to identify optimal param-
eters were done using Bst 3.0. We began by determining
the optimal thresholds for max rate, Fluorescence Intensity,
and amplification time. We demonstrate optimization of all
three parameters, using Tm as the arbiter, to illustrate the
utility of our method.
We tested the use of ROC curves (commonly used to indi-
cate clinical sensitivity and specificity) to compare the per-
formance in response to a given parameter. ROC curves
provide a visual representation of the ability to distinguish
between a true-positive and false-positive event, as a func-
tion of a given threshold, but can be difficult to use for op-
timal selection of LOD. ROC curves show the fractions of
true and false positives, where the true-positive fraction is
the number of true positives at a given threshold out of the
total number of true positives observed by Tm; and the false-
positive fraction is the number of false positives counted
at the given threshold, divided by the total number of false
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positives observed by Tm. A perfect classifying test will yield
the largest true-positive fraction and smallest false-positive
fraction.
When plotting the ROC curve for maximum rate (Supple-
mentary Figure S9A), we observed that rate initially per-
forms very well for eliminating false positives (the false-
positive fraction is very small for very high rates). How-
ever, as the digital threshold (analogous to ROC ‘cut-point’)
for rate decreases, a greater number of both false and true-
positive values are counted. Closer examination of this
range of thresholds (Supplementary Figure S9B) empha-
sizes the Youden Index at 34.6 true-positive fraction and
4.6 false-positive fraction as a possible choice for optimum
threshold, although the assay performance in terms of LOD
is unclear. The choice for optimal final-intensity threshold
is even less clear with the ROC curve (Supplementary Fig-
ure S9C), as the ROC curves do not give clear indication of
the optimal LOD (the ROC curve is a gentle concave slope).
Even relatively high fluorescence thresholds do not give in-
dications of the optimal cut-point (Supplementary Figure
S9D).
Filtering using LOD revealed a clear optimum. We plot
the total number of events for both true and false positives
and LOD as a function of maximum rate (Figure 7A). The
LOD curve revealed a clear minima, corresponding to the
optimal cut-point using rate. Selecting the threshold of 49.8
RFU/30 s generated an LOD of 2.11 ± 0.92 cp/l. Simi-
larly, plotting LOD against final intensity resulted in a clear
minima, despite the histogram appearing as a continuum
and the cut-point being thus ambiguous (Figure 7B). Using
final intensity, an LOD of 2.14 ± 0.89 cp/l can be achieved
at 1393 RFU.
The ROC curve for TTP presented a narrow range of
thresholds, with ∼50% true-positive fraction and 2% false-
positive fraction, although the precise optimal threshold
was not obvious (Supplementary Figure S9E). To refine this
threshold, we plotted the LOD and the cumulative counts
as a function of time in both linear (Figure 7C) and loga-
rithmic scales (Figure 7D).
Assays employing HRM only during the development of
the assay can improve the LOD of the final assays by select-
ing (making an informed choice of the optimum threshold).
The LOD decreases (blue curve) as the true positives begin
to amplify (blue dashed) and increases, as the false positives
amplify (red dashed). The minima for this system occurs
at 34 min and 0.93 ± 16 cp/l, striking a balance between
allowing many true positives to amplify and only a small
amount of false positives to occur (53.6% true-positive frac-
tion and 1.5% false-positive fraction) and is clearly defined
using the linear scale (Figure 7C). Plotting of LOD on the
logarithmic scale (Figure 7D) emphasizes improperly select-
ing a threshold can result in several orders of magnitude loss
in assay performance (for example, stopping the assay too
early or allowing the assay to run for too long). Although
dLAMP is robust to perturbations, selecting the appropri-
ate duration for amplification is important.
In contrast, assays using HRM as part of the final read-
out can distinguish false positives from the true positives
and improve LOD further by excluding non-specific ampli-
fication from the analysis. In some instances, an NTC may
incorrectly identify partitions as true positives by Tm (black
dashed). We incorporate these events as non-specific ampli-
fication in the case HRM is used in the final readout. If non-
specific amplification is eliminated, the assay LOD (Figure
7C and F, black solid) continues to improve with time, and
is only dependent on the stochastic probability that a true
positive will initiate and amplify. In this scenario, there is no
penalty allowing the assay to amplify for extended periods
of time.
In this scenario the LOD equation simplifies to
LOD = CTrue
NTrue/NCI
=∼ NCI
Fraction copies detected
(2)
Additionally, there is no limitation on the number of pa-
rameters that can be used to identify the optimal LOD. Us-
ing multiple parameters to filter the data may be useful for
individuals not employing HRM in the final assay or in as-
says only employing end-point measurement (e.g. an assay
without real-time measurements will be unable to generate
data on rate, but still benefit from selecting optimal assay
time and fluorescence threshold). As a demonstration, we
filtered first by optimal TTP, then for the optima of a sec-
ond parameter. In this case, we selected the optimal TTP of
34 min, and scanned for optimal fluorescence threshold. We
plotted LOD as a function of fluorescence threshold and de-
termined that the optimal fluorescence threshold at 34 min
would be 248 RFU and correspond to an LOD of 0.97 ±
0.16 cp/l (Figure 7E).
Do filter parameters exhibit the same LOD minima when
using Bst 2.0, as they did for Bst 3.0? Bst 2.0 had much
lower non-specific background than Bst 3.0, and could be-
have similarly or may behave differently.
First, does the ROC curve for TTP display a clear op-
timum? Similar to the TTP ROC for Bst 3.0 (Supplemen-
tary Figure S9E), the TTP ROC for Bst 2.0 has a concave
slope making choice of the optimum a matter of computa-
tion (Supplementary Figure S9F). We can visually estimate
the balance of true and false-positive fraction in the range
of 50% true and 10% false. Similar curves for max rate and
final intensity could be generated but are not shown here.
Second, is there an advantage to using HRM in the final
assay with Bst 2.0? To answer this question, we plot LOD
and the cumulative counts of true and false positives as a
function of time for Bst 2.0 (Figure 7F). Similarly to Bst
3.0, we observe LOD improve rapidly as true-positive events
are counted. However, unlike Bst 3.0, the non-specific am-
plification events are few and their presence does not have
an impact on LOD. Thus, when using Bst 2.0, the curves
representing LOD with or without HRM in the final assay
overlay and indicate using HRM in the final assay has no
additional benefit. Furthermore, the continuously decreas-
ing LOD with time for either case indicates that use of ROC
curves to determine an optimum can be misleading. While
the ROC implies that an optimum exists, the false-positive
incidence is rare enough that a TTP optimum selected by
LOD does not exist. Hence, assay developers may select as-
say time based on requirements other than LOD.
We next assessed whether we could use HRM to com-
pare the performance of the two polymerases, to see which
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/48/7/e42/5760753 by C
alifornia Institute of Technology user on 10 April 2020
PAGE 15 OF 21 Nucleic Acids Research, 2020, Vol. 48, No. 7 e42
Figure 7. Classification of amplification reactions using HRM to determine optimal performance of dLAMP assays. (A) Histogram of the false positives
identified by Tm within the presence of template (red), true positives by Tm (blue) and false positives in the NTC (green), binned by max rate of the partition
and an LOD curve plotted as a function of max rate using Bst 3.0. (B) Histogram of the false positives identified by Tm within the presence of template
(red), true positives by Tm (blue) and false positives in the NTC (green), binned by final intensity of the partition and an LOD curve plotted as a function
of final intensity using Bst 3.0. (C) LOD Curves using Bst 3.0 as a function of time without using in the final assay (blue) and using Tm in the final device
(black). Plots of cumulative counts of true positives (red dashed), false positives (blue dashed) and incorrectly identified partitions (black dashed). (D)
Logarithmic plot of LOD curves using Bst 3.0 as a function of time without using Tm in the final assay (blue) and using Tm in the final device (black). Plots
of cumulative counts of true positives (red dashed), false positives (blue dashed) and incorrectly identified partitions (black dashed). (E) LOD plotted as
a function of fluorescence intensity, when the assay is measured at the optimal TTP of 34 min. (F) Logarithmic plot of LOD curves, using Bst 2.0, as a
function of time without using Tm in the final assay (blue) and using Tm in the final device (black). The blue and black plots overlay. Plots of cumulative
counts of true positives (blue dashed), false positives (red dashed) and incorrectly identified partitions (black dashed). (G) Plot of LOD curves as a function
of time comparing Bst 2.0 (solid blue with Tm, dotted blue without Tm) and Bst 3.0 (solid red with Tm, dotted red without Tm). Curves for Bst 2.0 overlap.
one would give the best LOD and which combination of
hardware components would give the optimum assay per-
formance. (Figure 7G) For both polymerases we observed
a similar, rapid decrease in LOD in the initial moments as
true-positive events are detected. However, we also noticed
several differences. Bst 2.0 has a lower LOD than Bst 3.0 at
any amplification time. We attribute this difference to the
higher incidence of false positives when using Bst 3.0 com-
pared with Bst 2.0. An additional consequence of the low
false-positive incidence using Bst 2.0, regardless of the use
of HRM in the assay, is the LOD continues to improve with
time as additional true positives are counted. In contrast,
Bst 3.0 benefits greatly from use of HRM in the final as-
say. If HRM is not included in the assay (Figure 7G, red
dashed), a clear optimum for LOD occurs at 34 min and
0.93±0.16 cp/L. However, if HRM is employed in the as-
say, the LOD more closely resembles the LOD curve for Bst
2.0 and improves with increased detection of true-positive
events.
We made several overarching conclusions regarding im-
proving the LOD of dLAMP using a combination of dig-
ital real-time parameters and Tm. First, filter parameters
can be used singly or in combination to improve the per-
formance (LOD) of dLAMP. In certain assays one pa-
rameter may perform better than another for this selec-
tion. For this primer set, LOD for Bst 3.0 was lower (bet-
ter) when using TTP (0.93±0.16 cp/L) than max rate
(2.11±0.92 cp/L) or final intensity (2.14±0.89 cp/L).
Second, incorporation of HRM into the final assay read-
out will benefit some assays more than others. We ob-
served incorporation of HRM as a part of the final as-
say improved the perofmance of Bst 3.0 greater than
the perofmance of Bst 2.0, and was vital for long assay
times.
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Classification demonstrates host genomic DNA alters specific
and non-specific amplification in dLAMP
Assays with high clinical sensitivity and specificity are criti-
cally needed. Clinical samples of CT, originating from urine
and swabs, pose an intrinsic challenge because they contain
variable levels of host DNA, and DNA from other flora.
The analysis of these clinical samples, needs not only to be
sensitive (good LOD), but also able to function in the pres-
ence of non-specific, potentially amplifiable genomic sec-
ondary structures and other possible environmental con-
taminants, while remaining consistent between samples.
We sought to investigate the impact of host human ge-
nomic DNA (hgDNA) on non-specific background ampli-
fication. We hypothesized that non-specific structures (like
hairpins and regulatory elements), may amplify in the pres-
ence of LAMP and contribute to non-specific background
amplification. We titrated sheared buffy coat gDNA (i.e.
leukocytes) concentrations from zero to 2.5 × 103 cells per
l, a concentration 2.5× greater than that expected to cause
interference (8) and observed the impact on specific and
non-specific amplification of CT (Figure 8). We measured
the concentration of hgDNA in Human Haploid Genome
Equivalents (HHGE) or half the total amount of hgDNA
in a diploid cell. For each concentration of host DNA and
enzyme, we ran at least three chips in the presence of CT
template and three in the absence of template and across
multiple days and sample lots. In total, we observed 1 196
038 different reaction partitions. At the highest concentra-
tion of hgDNA, there was 3 030 000 times more hgDNA
than bacterial DNA by mass.
We first asked how background DNA impacted TTP
qualitatively. We observed for both Bst 2.0 and Bst 3.0 en-
zymes, specific and non-specific amplification were quali-
tative similar independent of background DNA concentra-
tion below 5000 HHGE per l. As with previous measure-
ments, Bst 2.0 rarely produced low-Tm non-specific events;
whereas Bst 3.0 produced both high- and low-Tm non-
specific events. Further, there were more non-specific am-
plification events for Bst 3.0 than Bst 2.0 at both high and
low Tm.
We next asked how background hgDNA impacts spe-
cific and non-specific amplification quantitatively. We cat-
egorized amplification events as specific and non-specific
based on Tm as previously. First, we asked: Is there a rela-
tionship between fraction of template molecules amplified
in dLAMP and amplification time? We then determined the
total number of template copies loaded into a chip relative
to the copies measured by ddPCR. If amplification initia-
tion is stochastic, as observed in Figures 5F and 6A-B, does
longer assay time increase ‘efficiency’ and thereby improve
LOD when using Tm (as seen in Figure 7C and F)? We ob-
serve that for Bst 2.0 a large number of partitions amplify
at in the first 11.5 min, followed by a second phase after
20 min where additional partitions amplify with lower fre-
quency (Figure 9A). The mode TTP for concentrations less
than 5000 HHGE per l was ∼11.6 ± 0.2 min (Supplemen-
tary Table S8 and Figures S10A-11C). After the mode TTP,
the frequency of observing specific amplification in the ab-
sence of HHGE decreases from a maximum frequency of
1.2 ± 0.1% copies detected per 30 s to a lower average fre-
Figure 8. Impacts of host (human) genomic DNA in human haploid
genome equivalents (HHGE) on specific and non-specific amplification.
Plots of Tm as a function TTP using Bst 2.0 at (A) 0 HHGE per l; (B)
0.01 HHGE per L, (C) 1 HHGE per l, (D) 100 HHGE per l and (E)
5000 HHGE per l; and using Bst 3.0 at (F) 0 HHGE per l, (G) 0.01
HHGE per l, (H) 1 HHGE per l, (I) 100 HHGE per l (J) 5000 HHGE
per l in the presence of template (blue) and NTC (red). N = 3 for all
conditions, except Bst 3.0 at 0 and 100 HHGE per l in the presence of
template, where N = 6.
quency of 0.23 ± 0.04% copies per 30 s from 20 to 90 min
(Figure 9A). For Bst 3.0 (Figure 10A), we observe a simi-
lar trend temporally, though mode TTP was at least 2 min
slower and had greater variability than Bst 2.0 (Supplemen-
tary Table S8, Figures S10B-11D). Further, Bst 3.0 consis-
tently amplified fewer target molecules than Bst 2.0 at all
time points. This highlights the stochastic nature of ampli-
fication using LAMP, and importance in choice of enzyme
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/48/7/e42/5760753 by C
alifornia Institute of Technology user on 10 April 2020
PAGE 17 OF 21 Nucleic Acids Research, 2020, Vol. 48, No. 7 e42
Figure 9. Quantification of the impact of hgDNA on specific and non-specific amplification using Bst 2.0 a as a function of time. (A) The percentage copies
detected (specific amplification) as a function of time. (B and C) The fraction of partitions with non-specific amplification with Tm less than the specific
amplification in the NTC (B) and in the presence of template (C) as a function of time. (D and E) The fraction of partitions with non-specific amplification
with Tm greater than the specific amplification in the NTC (D) and in the presence of template (E) as a function of time. Panel (A) is available in tabular
form as Supplementary Table S9.
Figure 10. Quantification of the impact of hgDNA on specific and non-specific amplification using Bst 3.0 as a function of time. (A) The percentage copies
detected (specific amplification) as a function of time. (B and C) The fraction of partitions with non-specific amplification with Tm less than the specific
amplification in the NTC (B) and in the presence of template (C) as a function of time. (D and E) The fraction of partitions with non-specific amplification
with Tm greater than the specific amplification in the NTC (D) and in the presence of template (E) as a function of time. Panel (A) is available in tabular
form as Supplementary Table S10.
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on sensitivity. In theory, assays employing Tm could be run
until all partitions amplify as either a false or true positive.
Allow all partitions to amplify would give the highest pos-
sible number of target copies amplified and lowest possible
LOD when using Tm in the final assay.
Second, we asked what is the impact of hgDNA on effi-
ciency as a function of time? For both Bst 2.0 and 3.0 (Fig-
ures 9A and 10A), when comparing within a given enzyme,
we observed that the fraction of copies detected and the mo-
ment the majority of reactions initiate, were indistinguish-
able for concentrations less than 5000 HHGE per l. At
5000 HHGE per l, a decrease in the fraction of copies de-
tected and a delay in amplification initiation was observed
(see also Supplementary Figure S11C and D). Bst 2.0 had a
mode TTP of delay of 4.7 min to 16.3 ± 2.7 min, whereas in
Bst 3.0, the mode TTP was 17.2 ± 2.1 min at 5000 HHGE
per l (Supplementary Table S8 and Figure S11). Thus, high
concentrations of hgDNA may suppress specific amplifica-
tion.
Third, we asked what is the impact of hgDNA and time
on non-specific amplification? For Bst 2.0, we observed con-
sistent non-specific amplification products with high and
low Tm, regardless of concentration of hgDNA. Single dig-
ital partition counts were observed at low-Tm non-specific
amplification in both the presence of template and the NTC
and independent of hgDNA concentration (Figure 9B and
C). The fraction of partitions generating a false-positive
amplification at low Tm was less than 3.3 × 10−4 through
45 min (i.e. 7 or fewer events in 20,000 partitions per chip).
Similarly, partition counts of high-Tm non-specific amplifi-
cation are <10 per chip until 45 min. After 90 min, high-
Tm non-specific amplification is more prevalent than low-
Tm non-specific amplification and the reactions finish with
fewer than non-specific 260 counts in 20,000 partitions cor-
responding to a false-positive fraction of 1.3 × 10−2. One
exception is the non-specific high-Tm amplification in the
absence template and HHGE. This condition appears to
have lower non-specific background than other conditions.
We collected each replicate on separate days and are able
to observe the experimental variability between the pres-
ence and absence fo template, which might be otherwise
lost when examining the NTC alone. This experiment em-
phasizes the advantage of determining non-specific amplifi-
caiton using Tm from the same experiment as specific ampli-
fication is counted. At low background rates, such as when
using Bst 2.0, inherant variability exists in the false-positive
fraction and can impact LOD. Measuring non-specific am-
plificaiton from within an experimental eliminates the as-
sumption that the false-positive rate remains identical to the
NTC or between experimental runs.
For Bst 3.0, non-specific amplification was variable, but
tended to be fewer for higher concentrations of hgDNA. At
any given time, high-Tm non-specific amplification was on
average ∼30-fold more likely to occur than a low-Tm non-
specific product. At 45 min, low-Tm non-specific amplifica-
tion had false-positive fraction <3.1 × 10−3 (62 or fewer
events per chip), amplification events with high Tm had a
false-positive fraction <1.9 × 10−2 (386 or fewer events per
chip). At the completion of the experiment, high-Tm non-
specific amplification events account for as much as 35% of
the total partitions per chip; a value exceeding the total ob-
served true-positive events. In these scenarios, utilization of
Tm to identify true and false amplification will be critical to
successful quantification of target analytes.
For this CT primer set, both Bst 2.0 and Bst 3.0 simi-
larly demonstrate that the presence of high concentrations
of hgDNA may suppress the likelihood of non-specific am-
plification occurring. In general, for this primer set and tar-
get, we find that Bst 2.0 performs significantly better than
Bst 3.0 as a consequence of having higher probability of de-
tecting a target molecule and low likelihood of generating a
non-specific amplification event.
Fourth, we asked is maximum rate impacted by the con-
centration of hgDNA? We hypothesize that background
hgDNA may compete for the binding site of the polymerase
with the target DNA or generate competing amplification
events and thus, decrease the maximum observed velocity
in a given partition. This phenomena would be challenging
to untangle in bulk. We find that maximum rates are simi-
lar for a given enzyme, until 5000 HHGE per l for Bst 2.0
(Supplementary Figure S11A) and above 100 HHGE per
l for Bst 3.0 (Supplementary Figure S11B). Thus demon-
strating that high concentrations of HHGE may slow the
rate of amplification. Furthermore, in general, and echo-
ing the conclusions of Figure 6G and I, we observe that Bst
2.0 has faster maximum rate than Bst 3.0, regardless of the
hgDNA concentration.
Fifth, we asked how is LOD impacted by the concentra-
tion of hgDNA? For Bst 2.0 (Supplementary Figure S11E),
the LOD at a given time was similar for concentrations
<5000 HHGE per l. While the LOD in the presence of
5000 HHGE per l was slightly worse from the detection of
fewer target molecules (e.g. 0.7 versus 0.5 cp/l at 45 min).
As previously, incorporation of HRM into the final assay
does not impact the LOD when using Bst 2.0. When using
Bst 3.0 (Supplementary Figure S11F) and HRM to remove
non-specific amplification, LOD tracks with the number of
true-positive events. Thus, LOD becomes worse when effi-
ciency is lower (i.e. at 5000 HHGE per l). Similarly, when
HRM is not incorporated in the assay, higher concentra-
tions of HHGE tend to result in a worse LOD. However,
at long amplification times, high concentrations of HHGE
suppress non-specific amplification more than specific am-
plification, resulting in LOD enhancement relative to low
concentrations of HHGE.
Cumulatively, these data show high background DNA
may reduce the probability of detecting a specific molecule
(analytical sensitivity), suppress the false-positive fraction
(analytical specificity), reduce the velocity of amplification,
and delay the start of amplification at clinically relevant
concentrations of hgDNA. Thus, we conclude background
hgDNA impacts dLAMP for this primer set. Generally,
investigators should examine their own primer sets in the
presence of high concentrations of hgDNA and take cau-
tion when examining clinical samples with high leukocyte
concentrations (as reported by urinanalysis). For example,
CT infection is not inherently associated with high con-
centrations of leukocytes and many infections are asymp-
tomatic. Ultimately, these experiments underscore the value
of quantifying non-specific amplificaiton variability, using
HRM, from within the same experiment as a target is
quantified. Because non-specific amplificaiton is measured
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within a given sample, one no longer needs to assume it re-
mains identical to the NTC or between experimental runs.
CONCLUSION
We predict that the combination of HRM and real-time
dLAMP will be invaluable for answering many questions
across a wide variety of applications, and thus our approach
was designed to be accessible to most standard labs. We
employed commercial chips for digitization, a commercial
thermoelectric unit for heating and cooling, a commercial
microscope for optical analyses and we made our data-
processing script freely available. Our intention was to de-
sign an accessible system with readily available components
to enable others to access the advantages of digital microflu-
idics to study and optimize primer sets, enzymes, and reac-
tion conditions of interest to them. We predict these capa-
bilities will be particularly valuable for people working with
variable sample matrixes, high background DNA, poorly
performing primer sets, or poorly performing enzymes.
We derived four major lessons from this study. First,
LAMP can produce non-specific amplicons with high Tm.
The formation of these non-specific amplicons occurs from
the interaction of multiple primers and the use of a poly-
merase with template switching ability, terminal transferase
activity and lacking 3′–5′ exonuclease activity. Interaction
of primers may lead not only lead to rising background flu-
orescence (37), but to spontaneous exponential amplifica-
tion as well. Primer design and enzyme selection therefore
should be judicious to avoid formation of hairpins within
primers, as well as microhomology at the 3′ with any other
primer, in order to prevent non-specific amplification.
Second, HRM in LAMP is a useful method for differen-
tiating specific and non-specific amplification events. Digi-
tal experiments measure the fate and rate of each template,
in contrast, bulk experiments are biased toward early am-
plification events. The combination of dLAMP and HRM
allows observation of many amplification events and assign-
ment of the nature of that amplification as true or false. Fur-
ther, dLAMP with HRM quantifies non-specific amplifica-
tion experimentally in the presence of specific amplification,
eliminating the assumption that incidence of false positives
in the presence of template remains identical to the NTC or
between experimental runs.
Third, by differentiating specific and non-specific ampli-
fication, HRM is helpful in determining the combination
processing and assay parameters that will lead to the best
LOD in a digital assay. When HRM is incorporated into a
dLAMP assay, true and false-positive amplification events
can easily be separated. LOD is improved by elimination
of non-specific background and thus becomes dependent
on the number of molecules that amplify (i.e. amplifica-
tion efficiency or fraction of copies detected), without de-
pendence on the incidence of false positives. In contrast, if
HRM were employed in a bulk reaction, the LOD would
still be limited by the competition between specific and non-
specific amplification (which amplifies first) and would re-
quire a high number of trials to achieve sufficient statistical
power. Importantly, even when HRM will not be used in
the final assay, it can still be incorporated during the assay-
development stage to improve the assay’s LOD by determin-
ing the optimal choice of parameters based on rate, TTP, fi-
nal intensity or any combination of these parameters. Fur-
thermore, our mathematical description of LOD is general-
izable to other amplification methods that are measured in
digital and can separate specific and non-specific amplifica-
tion.
Fourth, high levels of non-specific host gDNA suppress
analytical sensitivity and specificity, reduce amplification
velocity, and delay the start of amplification. However, low-
to-moderate levels of non-specific host gDNA do not im-
pact the analytical specificity or sensitivity of dLAMP. We
ran our assays through clinically relevant concentrations of
background DNA and did not observe interference until the
upper range of concentrations expected to cause interfer-
ence to demonstrate the clinical utility of real-time dLAMP
with HRM.
Real-time dLAMP with HRM will enable the mechanis-
tic optimization of primers and myriad assay conditions
(such as buffer, Mg2+ and reaction temperature). Because
real-time dLAMP with HRM reveals the incidence of non-
specific amplification products with high and low Tm as a
function of time, dLAMP with HRM can be used to inves-
tigate approaches that will eliminate different non-specific
products. For example, fast or early non-specific events in
digital may indicate primers or conditions that will be es-
pecially vulnerable to failure in a bulk reaction. Thus, real-
time dLAMP with HRM could be used to design primers
that will suppress non-specific amplification in bulk, by gen-
erating only non-specific amplicons that occur at slow rates
and late TTP.
Future efforts should investigate the combination of real-
time dLAMP (and other digital isothermal amplification
technologies) and HRM as a way to increase multiplexing
of dLAMP when using a single reporter. In PCR, HRM
has been used to differentiate among multiple amplification
products by measuring differences in Tm (42–46), with ap-
plications that include among others multiplexed pathogen
identification and antibiotic susceptibility testing. Finally,
studies with clinical samples should be performed using the
dLAMP with HRM method to understand the carryover
effects from relevant matrices.
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